by Jordana Choucair | Mar 18, 2022 | Life Sciences
The Medicines Patent Pool (MPP), a U.N.-backed organization, announced that 35 manufacturers agreed to produce generic forms of Paxlovid – Pfizer’s oral antiviral treatment for COVID-19. Six companies will focus on producing the substance of the drug, nine...
by Jordana Choucair | Mar 18, 2022 | Life Sciences
Moderna asked the FDA for emergency authorization of a second booster of its COVID-19 vaccine for all adults. The request is significantly broader than Pfizer’s and BioNTech’s request, which asked the agency to authorize its second booster for adults 65 and older....
by Jordana Choucair | Mar 18, 2022 | Payers
A new Humana study found that value-based care can drive down acute care episodes among Medicare Advantage (MA) beneficiaries. According to the research, MA members treated by doctors in advanced value-based care models had 5.6 percent fewer hospitalizations and 13.4...
by Jordana Choucair | Mar 18, 2022 | Providers
Health and Human Services (HHS) Secretary Xavier Becerra said that the department may readjust Medicare Part B premiums next month. Becerra also indicated that the department is interested in talking to Congress about Medicare Advantage overpayment issues and...
by Jordana Choucair | Mar 18, 2022 | Transition to Value
The House Progressive Caucus released a list of recommendations that encourage the Biden administration to end the ACO REACH payment model. According to the caucus, the model, which was formerly called the Direct Contracting payment model, enables “third-party...
Recent Comments